Skip to main content

Federman & Sherwood Investigates Enzo Biochem for Data Breach

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The law firm of Federman & Sherwood has initiated an investigation into Enzo Biochem with respect to their recent data breach. On May 30, 2023, Enzo Biochem notified 2.47 million patients that the company experienced a data breach after an unauthorized party accessed sensitive consumer data entrusted to the company. According to Enzo Biochem, they determined that information stored on their servers may have been subject to unauthorized access on April 6, 2023. Enzo Biochem determined that the information exposed in the data breach includes: names, addresses, Social Security numbers, driver’s license numbers, financial information, medical information and health insurance information.

If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Lacrista A. Bagley either by email at lab@federmanlaw.com or visit our firm’s website www.federmanlaw.com.

Contacts

Lacrista A. Bagley

FEDERMAN & SHERWOOD

(405) 235-1560

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.91
+1.63 (0.66%)
AAPL  266.17
-6.88 (-2.52%)
AMD  284.49
+9.54 (3.47%)
BAC  53.48
-0.47 (-0.87%)
GOOG  330.47
-4.93 (-1.47%)
META  668.84
-2.07 (-0.31%)
MSFT  424.16
+6.09 (1.46%)
NVDA  199.88
-2.18 (-1.08%)
ORCL  181.17
+3.59 (2.02%)
TSLA  386.42
-6.08 (-1.55%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.